Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080977
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
2004-04-07
Brief Title:
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma Kidney Cancer That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Sponsor:
Blumenthal Cancer Center at Carolinas Medical Center
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000357581
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blumenthal Cancer Center at Carolinas Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None